Disclosures for "Acute Autoimmune Limbic Encephalitis Associated with GABABR Antibody in a Patient with Advanced Squamous Cell Carcinoma of the Cervix Treated with Pembrolizumab: A Case Report"
-
Dr. Jha has nothing to disclose.
-
Dr. Gluck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen.
-
Dr. Khan-Tareen has nothing to disclose.